Results 101 to 110 of about 41,093 (226)

Advances of Precise Radiotherapy for Lung Cancer

Chinese Journal of Lung Cancer, 2011
At present lung tumor radiation therapy has entered the accurate radiotherapy era. Precise radiotherapy includes intensity modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT) and stereotactic body radiotherapy (SBRT).
Xin WANG, Feng XU, Yuquan WEI
doaj   +1 more source

A sample size analysis of a mathematical model of longitudinal tumor volume and progression‐free survival for Bayesian individual dynamic predictions in recurrent high‐grade glioma

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 495-509, March 2025.
Abstract Patients with recurrent high‐grade glioma (rHGG) have a poor prognosis with median progression‐free survival (PFS) of <7 months. Responses to treatment are heterogenous, suggesting a clinical need for prognostic models. Bayesian data analysis can exploit individual patient follow‐up imaging studies to adaptively predict the risk of progression.
Daniel J. Glazar, Solmaz Sahebjam, Hsiang‐Husan M. Yu, Dung‐Tsa Chen, Menal Bhandari, Heiko Enderling   +5 more
wiley   +1 more source

A Case of Complete Remission Achieved Through Stereotactic Radiotherapy for Isolated Bone Metastasis Following Four Courses of Bleomycin, Etoposide, and Cisplatin Chemotherapy for Testicular Cancer

IJU Case Reports
Introduction We report a case of nonseminoma germ cell tumor, in which solitary bone metastasis was detected by magnetic resonance imaging (MRI) after systemic chemotherapy, and resolution was achieved with stereotactic radiotherapy.
Kentaro Arinami, Gen Kawaguchi, Kozue Ito, Yurie Takizawa, Go Hasegawa, Yohei Ikeda, Noboru Hara, Tsutomu Nishiyama   +7 more
doaj   +1 more source

Metastatic prostate cancer recurrence within a percutaneous computed tomography guided needle biopsy tract: A rare case report

UroPrecision, EarlyView.
Abstract Background Metastatic prostate cancer tumor seeding within a percutaneous biopsy tract is rare. While reports of tumor seeding following perineal and transrectal prostate biopsies exist, no cases of prostate cancer tumor seeding along a metastatic percutaneous bone biopsy tract detected by prostate specific membrane antigen (PSMA) positron ...
Thomas Neerhut, Thomas McMaster, Abigail Attwell‐Heap, Michael Kreltszheim   +3 more
wiley   +1 more source

Thermal Ablation and Rapid On‐Site Cytology for Lung Nodules—A ‘One‐Stop Shop’ Approach for Small Lesions: Experience in 8 Patients

Journal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT Aim This technical report describes our experience with eight patients with small lung lesions (less than 2 cm) treated by thermal ablation after rapid on‐site cytological confirmation of cancer diagnosis. Materials and Methods Six patients were treated by microwave ablation and two by cryoablation, under local anaesthesia.
Andrei B. Gorgos, Damien Olivié, Philippe Stephenson, Edith Filion, Houda Bahig   +4 more
wiley   +1 more source

Stereotactic fractionated radiotherapy for multiple brain metastasis treated with single isocenter multitargeted approach: a case report

Journal of Current Oncology and Medical Sciences
Introduction: Adult patients with solid cancers frequently develop brain metastases. Whole brain radiotherapy (WBRT) alone or Stereotactic radiosurgery/radiotherapy (SRS/SRT) alone or in combination can be considered in Brain metastasis.
Siddharth Arora , Kriti Grover
doaj  

Stereotactic Body Radiaton Therapy for 15 Patients with Small Lung Neoplasms

Chinese Journal of Lung Cancer, 2011
Background and objective It has been known that stereotactic radiotherapy has been widely used in clinical practice. The aim of this study is to evaluate the feasibility to treat small lung neoplasms with hypofraction stereotactic radiotherapy.
Rong YU, Yongheng LI, Guangying ZHU
doaj  

Advances and Future Perspectives for the Management of Non‐Small Cell Lung Cancer in Australia: A Narrative Review

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Lung cancer remains Australia's leading cause of cancer death. With new screening and evolving therapies, equitable access and workforce readiness are essential. This review discusses current and emerging treatments for NSCLC in Australia, clinical trials underway, and future directions in delivering optimal, accessible care nationwide.
Lauren Julia Brown, Graham Meredith, Bo Gao, Pei Ding, Harriet Gee, Inês Pires da Silva, Adnan Nagrial, Eric Hau   +7 more
wiley   +1 more source

Real‐World Survival Outcomes in EGFR‐Mutant Advanced NSCLC Treated With EGFR TKIs: Insights From a Single‐Center Clinical Data Warehouse Analysis in South Korea

Asia-Pacific Journal of Clinical Oncology, EarlyView.
This retrospective cohort study was conducted using clinical data derived from a single‐center clinical data warehouse (CDW). In Korean patients with EGFR‐mutant advanced NSCLC, first‐line treatment with 3G EGFR TKIs (osimertinib or lazertinib) demonstrated significantly better overall survival than 1G or 2G agents.
Bomi Kim, Sunghoon Kang, Iksoo Huh, Hyeoneui Kim   +3 more
wiley   +1 more source

Management of Advanced Prostate Cancer in the Asia‐Pacific Region: Summary of the Asia‐Pacific Advanced Prostate Cancer Symposium 2025

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Summary of the Asia Pacific Advanced Prostate Cancer Symposium 2025, showing disciplines and diversity of participants, discussion topics (high‐risk localized/locally advanced prostate cancer; PSA persistence and recurrence; radioligand therapy; genetics and genomics; bone protection and other aspects of supportive care), key themes, and high‐level ...
Edmund Chiong, Renu Eapen, Nicholas Buchan, Kenneth Chen, Lukman Hakim, Agus Rizal Hamid, Jae‐Young Joung, Ravindran Kanesvaran, Makarand Khochikar, Jason Letran, Bannakij Lojanapiwat, Indranil Mallick, Chi Fai Ng, Pei Ing Ngam, Teng Aik Ong, Jacob Pang, Darren M. C. Poon, Natasha Roberts, Marniza Saad, Shinichi Sakamoto, Jeremy Tey, Sue Ping Thang, Poh Choo Toh, Levent Türkeri, Nguyễn Tuấn Vinh, Alvin Wong, Yao Zhu, ANZUP Cancer Trials Group, Ian D. Davis   +28 more
wiley   +1 more source